Tweeter button Delicious button Digg button Stumbleupon button
Fatty Liver Disease | New Data Presented At Digestive Disease Conference May Change Prognosis For Many Patients

CHICAGO, May 6, 2014 /PRNewswire/ –Research presented this week at Digestive Disease Week (DDW) provides insight into the development and new treatments of diseases, such as nonalcoholic fatty liver disease, colorectal cancer and ulcers. Key studies presented include:

Weight-loss surgery can reduce liver damage . Bariatric surgery, which is best known for its ability to help patients lose weight, can also result in improvement in nonalcoholic fatty liver disease by reducing fat deposits in the liver. (Abstract 233)

Vibrating capsule shows promising results in treating constipation. An oral capsule that vibrates as it moves through the digestive tract has shown notable promise as a non-pharmacological treatment for constipation. (Abstract Sa2023)

Lean patients with fatty liver disease have a higher mortality rate . In addition to higher mortality rates than overweight or obese patients, research finds that lean patients with nonalcoholic fatty liver disease were more likely to be male, non-Caucasian and to have lower rates of chronic conditions. ( Abstract 379 )

Treatment guidelines for bleeding ulcers may need revision. Research shows that the standard care plan after endoscopic treatment of bleeding ulcers should be replaced by an alternate method that may be less costly and more comfortable for patients. (Abstract 331)

Dual method to remove precancerous colon polyps may substantially reduce

Click here to view rest of article from original site

Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.